<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/2003" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/2003/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/2003/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_2003"><akn:num>2003</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>§ 2003. Authorization of appropriations
There are authorized to be appropriated to the United States Anti-Doping Agency—(1) for fiscal year 2023, $15,500,000;

(2) for fiscal year 2024, $16,200,000;

(3) for fiscal year 2025, $16,900,000;

(4) for fiscal year 2026, $17,700,000;

(5) for fiscal year 2027, $18,500,000;

(6) for fiscal year 2028, $19,800,000;

(7) for fiscal year 2029, $22,100,000;

(8) for fiscal year 2030, $24,900,000; and

(9) for fiscal year 2031, $23,700,000.

(Pub. L. 109–469, title VII, § 703, Dec. 29, 2006, 120 Stat. 3534; Pub. L. 113–280, § 3, Dec. 18, 2014, 128 Stat. 3020; Pub. L. 117–103, div. Q, title III, § 304, Mar. 15, 2022, 136 Stat. 817.)

Editorial Notes
Amendments2022—Pub. L. 117–103 amended section generally. Prior to amendment, section related to appropriations for fiscal years 2014 to 2020.
2014—Pub. L. 113–280 amended section generally. Prior to amendment, section related to authorization of appropriations for fiscal years 2007 to 2011.</akn:p></akn:content><akn:subsection eId="subsec_2003_1"><akn:num>(1)</akn:num><akn:content><akn:p>(1) for fiscal year 2023, $15,500,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_2"><akn:num>(2)</akn:num><akn:content><akn:p>(2) for fiscal year 2024, $16,200,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_3"><akn:num>(3)</akn:num><akn:content><akn:p>(3) for fiscal year 2025, $16,900,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_4"><akn:num>(4)</akn:num><akn:content><akn:p>(4) for fiscal year 2026, $17,700,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_5"><akn:num>(5)</akn:num><akn:content><akn:p>(5) for fiscal year 2027, $18,500,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_6"><akn:num>(6)</akn:num><akn:content><akn:p>(6) for fiscal year 2028, $19,800,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_7"><akn:num>(7)</akn:num><akn:content><akn:p>(7) for fiscal year 2029, $22,100,000;</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_8"><akn:num>(8)</akn:num><akn:content><akn:p>(8) for fiscal year 2030, $24,900,000; and</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2003_9"><akn:num>(9)</akn:num><akn:content><akn:p>(9) for fiscal year 2031, $23,700,000.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>